Hematologist
CION Cancer Clinics
How MRD results guide treatment in adult ALL | CION Cancer Clinics
MRD-guided treatment means your plan follows a very sensitive test for leukaemia left behind after treatment, called minimal residual disease. When no leukaemia is detected, treatment usually stays on course. When it is still detected, the team may add a targeted drug or discuss a transplant. This page explains when MRD is tested, what the report words mean, and what a result can and cannot tell you. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
The short answer
What does MRD-guided treatment mean in adult ALL?
MRD-guided treatment means your plan is adjusted according to a very sensitive test for leftover leukaemia, called minimal residual disease (MRD). If no leukaemia is detected, treatment usually continues as planned. If leukaemia is still detected, the team may step up treatment, add a targeted drug or discuss a transplant.
Why remission alone is not enough
Remission means no leukaemia can be seen under a microscope. But a microscope only spots leukaemia when there are a lot of cells. A person in remission can still carry a hidden amount. MRD tests find leukaemia at levels hundreds or even thousands of times lower than a microscope can.
Why it matters so much in ALL
In adult ALL, the MRD result is one of the strongest signs of how likely the leukaemia is to come back. It often matters as much as the genetics. That is why most modern protocols build their decisions around it, rather than giving everyone the same treatment regardless of response.
What it means for the family
Because the plan can change at each MRD check, it helps to know the dates of those checks in advance. A result that points towards a transplant, for example, can mean brothers and sisters are asked for a simple tissue-typing test within weeks. Knowing this early gives the family time to plan work leave, travel and money, instead of reacting in a hurry when the report arrives.
What it does not replace
MRD is read alongside the type of ALL, the genetic changes, your age, your fitness and how you have coped so far. A single result is one piece of the picture, not a verdict on its own.
The timing
When is MRD tested during treatment?
At diagnosis
The first marrow sample records the leukaemia's fingerprint, the markers or genetic changes the lab will look for later. Without it, later MRD testing is harder.
End of induction
The first key MRD check. It shows how quickly the leukaemia responded to the first phase of treatment.
During consolidation
A second check some months in. Leukaemia that is still detectable here is taken very seriously, and the plan often changes.
Before transplant and in follow-up
MRD is checked before any transplant, and sometimes afterwards, to spot a returning leukaemia before it causes symptoms.
Not sure whether this applies to you?
Ask an oncologistOn your report
What do the words on an MRD report mean?
- Flow cytometry
- A lab machine that checks thousands of cells one by one for the leukaemia's surface markers. Results usually come back quickly.
- PCR
- A genetic test that looks for a change unique to your leukaemia, such as BCR-ABL1. It can be more sensitive than flow cytometry.
- NGS
- Next-generation sequencing. A newer genetic method that can detect extremely low levels, but it is not available everywhere.
- MRD negative or not detected
- No leukaemia found at the level the test can measure. It does not prove that none is present.
- Positive, not quantifiable
- A trace was found, but too small to measure accurately. Your team will explain how they read it.
- Sensitivity
- The smallest level of leukaemia the test can find. Always ask what it was for your result.
From result to plan
How might your result change the plan?
These are typical directions, not rules. Each protocol sets its own decisions, and your haematologist applies them to you.
Not detected
Treatment usually continues on the planned path. For some people this means a transplant can be avoided, or treatment intensity can stay as it is.
Detected at the end of induction
Often expected to fall with consolidation. The team watches the next result closely before making big changes.
Still detected later
This is a higher-risk sign. The team may suggest a targeted antibody such as blinatumomab, and discuss a donor transplant.
Often started
- Search for a suitable donor
- Tumour board review
Becomes detectable again
After a negative result, a return can be an early warning of relapse. Repeat testing and a new plan follow promptly.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Being straight with you
What can an MRD result not tell you?
An MRD result cannot tell you on its own whether the leukaemia will come back. A negative result lowers the chance, but some people with a negative result still relapse. A positive result raises the chance, but it is a reason to act, not a reason to lose hope.
Results from different labs are not always comparable
Flow cytometry, PCR and NGS measure in different ways and at different sensitivities. A result from one lab cannot always be set against a result from another. Where possible, ask for tests to be repeated by the same method, and keep copies of every report in one folder.
Who may not get an MRD-guided plan
If the diagnostic sample was not suitable for setting up MRD tracking, or the test is not accessible, decisions lean more on genetics and the microscope result. Some older or less fit adults on gentler plans may be tested less often, because the result would not change what is possible.
What to ask your team
Ask which method was used, what its sensitivity was, what the result means for the next phase, and when the next test is due. CION's haematology team reviews results with a tumour board and coordinates specialised testing with qualified laboratories where needed.
Commonly believed
What do families often misread in MRD results?
"MRD negative means the leukaemia is gone for good."
It means none was found at the level the test can reach. It is very good news, but treatment still needs to be completed as planned.
"MRD positive means treatment has failed."
It means some leukaemia remains and the plan may need to change. Options such as antibody drugs or transplant exist precisely for this situation.
"A tiny number on the report is nothing to worry about."
In ALL, even a very small persistent level can matter. Let your haematologist interpret it rather than judging by the size of the number.
"Repeated marrow tests are only for research."
Each test is used to decide your own next step. Skipping one can mean a decision is made with less information.
Did you know
MRD testing depends on the very first bone marrow sample taken at diagnosis. If you are moving your care to a new centre, bring every earlier marrow, flow cytometry and genetic report with you, so the new team can keep tracking the same leukaemia markers.
Questions we are asked
Common questions about MRD-guided treatment in ALL
Is MRD tested from blood or bone marrow?
Usually from bone marrow, because leftover leukaemia is easier to find there than in the blood. Some PCR tests, such as BCR-ABL1 in Philadelphia-positive ALL, can also be followed in blood between marrow tests. Your team will tell you which sample each check needs.
How long do MRD results take?
Flow cytometry results often come within a few days. PCR and NGS can take longer, especially if the sample is sent to a specialised laboratory. Ask when to expect the result, and who will call you to explain it, so you are not left waiting without news.
Is MRD testing available in India?
Yes. Flow cytometry MRD testing is offered by several laboratories in India, and PCR testing is available for some genetic changes. NGS-based testing is less widely available. Your haematologist will arrange the test through a qualified laboratory suited to your leukaemia's markers.
Does a positive result mean we need a transplant?
Not always. A persistent positive result makes a transplant more likely to be discussed, but the decision also depends on genetics, your fitness, donor availability and whether an antibody drug can clear the MRD first. Ask the team to explain every option and why they favour one.
Can MRD results be wrong?
Every test has limits. A poor sample, blood mixed into the marrow, or leukaemia cells that change their markers can affect the result. That is why a surprising result is often repeated, and why results are read alongside the rest of your picture rather than alone.
Is MRD testing covered by schemes or insurance?
Sometimes. Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance may cover leukaemia tests as part of a treatment package, but specialised tests are not always included. Rules change, so check your current cover and ask the insurance desk before the sample is sent.
What should we do with the report at home?
Keep it safely with your other reports, but try not to interpret it alone. Wording written for doctors can sound far more alarming than it is. Write down your questions and bring them to the next appointment, or call the team if waiting is hard.
Does MRD matter in Philadelphia-positive ALL too?
Yes. In Philadelphia-positive ALL the BCR-ABL1 level is tracked by PCR, and a deep response can shape decisions about transplant and how long the targeted tablet continues. The principles are the same, although the test and its cut-offs may differ.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Adult Acute Lymphoblastic Leukemia Treatment (PDQ), Patient Version
- National Cancer Institute — Definition of minimal residual disease
- Leukemia & Lymphoma Society — Acute Lymphoblastic Leukemia (ALL)
- Cancer Research UK — Acute lymphoblastic leukaemia (ALL)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Acute Lymphoblastic Leukaemia in AdultsThe overview of adult ALL, from diagnosis onwardsAdult ALL Treatment: The Phases ExplainedWhere each MRD check falls in the planBlinatumomab and Inotuzumab in Adult ALLA common next step when MRD stays positiveWhen Adult ALL Needs a TransplantHow MRD feeds into the transplant decision
Talk to us
Have an MRD report you are unsure about?
Tell us what has been found so far. CION's haematology team will go through the result with you and help you reach the right specialist. One helpline serves every CION centre.